Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Environmental scandal in Chile

June 22, 2010 5:38 pm | by EurekAlert | News | Comments

(Max-Planck-Gesellschaft) A Gottingen scientist discovers hitherto unknown impacts of Chilean salmon farms on coastal ecosystem.

TOPICS:

Genetically modified cell procedure may prove useful in treating kidney failure

June 22, 2010 5:38 pm | by EurekAlert | News | Comments

(Indiana University School of Medicine) A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure. Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory...

TOPICS:

Hanger Orthopedic Group, Inc. Announces Three Acquisitions With Annual Revenues of $14.0 Million

June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | Comments

BETHESDA, Md. , June 22 /- Hanger Orthopedic Group, Inc. (NYSE: HGR ) announced that it continues to expand its geographic presence with  the acquisition of Dynamic Orthotics and Prosthetics of Texas , Nebraska Orthotic and Prosthetic Services, and Spectrum Prosthetics and Orthotics...

TOPICS:
Advertisement

TheraQuest Unveils New Pain Management Product Pipeline

June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa. , June 22 /- TheraQuest Biosciences, Inc., a clinical stage pain management company today unveiled its analgesic product pipeline. TheraQuest also announced the launch of its new corporate website at http://www.theraquestinc.com . Najib Babul, PharmD, President and Chief...

TOPICS:

Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)

June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill. , June 22 /- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials.  The medication, a...

TOPICS:

Tolera Therapeutics Granted Orphan Drug Designation for Treatment of Type 1 diabetes mellitus

June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | Comments

KALAMAZOO, Mich. , June 22 /- Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM)....

TOPICS:

Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance

June 22, 2010 5:36 pm | by Bio-Medicine.Org | News | Comments

STEWARTVILLE, Minn. , June 22 /- Rochester Medical Corporation (Nasdaq: ROCM ) today announced that it is a winner of the fifth annual Pinnacle Award, presented by the Premier healthcare alliance. Premier contracts with more than 800 suppliers and Rochester Medical is one of 38 contracted...

TOPICS:

Anthem Healthcare Intelligence Teams with Oracle to Offer Healthcare Analytic Applications

June 22, 2010 5:36 pm | by Bio-Medicine.Org | News | Comments

LAS VEGAS , June 22 /- Anthem Healthcare Intelligence, Inc. is pleased to announce that they are working with Oracle to provide business intelligence and performance management applications.  Anthem will offer its provider specific analytic applications on Oracle's new Enterprise...

TOPICS:
Advertisement

BCM home nurse program helps young mothers, children

June 22, 2010 5:36 pm | by Baylor College of Medicine | News | Comments

An innovative program at the Baylor Teen Health Clinic designed to improve the health and well being of young first-time mothers and their children is celebrating its successes since launching nearly two years ago. The Nurse-Family Partnership program offers home-based nurse services to...

TOPICS:

TomoTherapy signs deal with Amerinet

June 22, 2010 2:45 pm | by The Associated Press | News | Comments

Radiation therapy device maker TomoTherapy Inc. said Tuesday it signed a services deal with health care group purchasing organization Amerinet.The deal will make TomoTherapy's radiation therapy systems available to Amerinet's members. Amerinet has more than 41,000 members nationwide.Financial...

Health insurers dip modestly on reform update

June 22, 2010 12:45 pm | by TOM MURPHY - AP Business Writer - Associated Press | News | Comments

Shares of major health insurers fell modestly Tuesday, as investors digested a White House explanation of how several elements of health care reform will unfold later this year.Shares of companies like WellPoint Inc. and UnitedHealth Group Inc. posted frequent wide swings last year at least...

Somanetics 2Q net income falls 15 percent on costs

June 22, 2010 7:45 am | by The Associated Press | News | Comments

Medical device maker Somanetics Corp. said Monday its second-quarter net income fell 15 percent on higher operating expenses.The company earned $1.5 million, or 12 cents per share, down from $1.8 million, or 14 cents per share, in the year-ago period. Net revenue climbed 17 percent to $13.9...

SEK100 million ($12.83 million) for Karolinska Institutet's research into regenerative medicine

June 22, 2010 7:39 am | by EurekAlert | News | Comments

(Karolinska Institutet) The Swedish medical university Karolinska Institutet has received a grant of SEK100 million ($12.83 million) from the Knut and Alice Wallenberg Foundation for a regenerative medicine research center -- the Wallenberg Institute for Regenerative Medicine. This...

TOPICS:

Judge tells state to reconsider contract

June 22, 2010 6:45 am | by The Associated Press | News | Comments

A judge Monday ordered the state to reconsider its award of a contract to Blue Cross and Blue Shield of Louisiana to administer the HMO health plan for state workers, retirees and their dependents.Humana previously held the contract, which is scheduled to take effect July 1."Humana has...

Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes

June 22, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS and BENTONVILLE, Ark. , June 22 /- Walmart (NYSE: WMT ) and Eli Lilly and Company (NYSE: LLY ) announced today they're teaming up to provide an affordable insulin option for people with diabetes.   Beginning in mid-September, Lilly's Humulin ® brand of insulin will...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading